![alumni](https://pharmacology.weill.cornell.edu/sites/default/files/pages/alumnicurrentpos.jpg)
Alumni - Current Positions
If you are an alumnus and your information is not up to date, please contact Aileen Rosales at (212) 746-6250 to provide us with your current information.
(updated 06/2024)
Name | Year of Graduation | Advisor's Name | Thesis Project | Current Position |
---|---|---|---|---|
Jacob Lesniak | 2004 | Nikolov, Dimitar | Structural and Functional Characterization of Pseudomonas Aeruginosa Ohr and Escherichia coli OsmC Organic Hydroperoxide Resistance Proteins. | Staff Toxicologist, Regeneron Pharmaceuticals |
Stephen Pitt | 2004 | Patel, Dinshaw | Probing RNA-Ligand Recognition by NMR Spectroscopy: Residual Dipolar Couplings in the Determination of HIV-1 TAR RNA Structural Dynamics. | Staff Scientist, Formulation Development, Drug Development Operations, Johnson & Johnson |
Nancy Skacel | 2004 | Bertino, Joseph | Characterization of the Functional Dihydrofolate Translational Up-Regulation Response Upon Antifolate Treatment and Comparison Among Species. | Assistant Professor, Department of Pharmacology and Physiology, Gourge Washington School of Medicine and Health Sciences, |
Ardesheer Talati | 2004 | Hirsch, Joy | Cortical Systems that Integrate Sensory Information: An fMRI Study. | Faculty Member & Associate Research Scientist, Department of Psychiatry, Columbia University Medical Center |
Juliana Xu | 2004 | Gudas, Lorraine | Functional Studies of REX-1 Target Genes using F9 Teratocarcinoma Stem Cells as a Model System. | Chief Technology Officer, Agria Corporation, NY |
John Biggins | 2003 | Thorson, Jon | The Mechanism of CalC - A Protein Conferring Self-Resistance to the Antitumor Antibiotic Calicheamicin within micromonospora echinospora ssp. calichensis | Chemical Biologist, LifeMine Therapeutics- Biotechnology Drug Development, Cambridge, MA |
Barbara Franklin (Gorfajn) | 2003 | Terminal Masters | Update coming soon | |
Jack Liao | 2003 | Fisher, Robert | PNQALRE, A Novel CDK Family Member, Associates with CDK-Activating Kinase (CAK) in vivo, and is Required for Normal Proliferation of Mammalian Cells in Culture. | Postdoctoral Fellow, The Donaldson-Atwood Cancer Clinic, The Animal Medical Center |
Tatiana Litvin | 2003 | Buck, Jochen | A Novel Mechanism of Adenylyl Cylcase Activation Conserved from Cyanobacteria to Man | Assistant Director, Office of Patents and Licensing, UMDNJ |
Pellegrino Magro | 2003 | Bertino, Joseph | The Effect of p14ARF on DHFR and its Implications on Antifolate Drug Sensitivity. | Scientific Director, MedLearning, Inc. |
Angelo Russo | 2003 | Bertino, Joseph | Examination of the Role of E2F-1 in the Cellular Response to Antimitotic Agents | Associate Medical Director/Medical Writer, Lowe Healthcare Company, Integrated Communications |
Andrea D. Basso | 2002 | Rosen, Neal | Regulation of Akt Expression and Signaling by the Hsp90 Chaperone. | Associate Principal Scientist, Schering-Plough Research Institute |
Elizabeth Bolan | 2002 | Scotto, Kathleen | Molecular and Pharmacological Characterization of Mu Opioid Receptor Hetergeneity. | Pharmacologist, FDA |
Gina Capiaux | 2002 | Bertino, Joseph | A Fusion Protein of Mutant Dihydrofolate Reductase and Mutant Thymidylate Synthase for Conferring Myeloprotection against Methotrexate and 5-Fluorouracil: Characterization and in vivo Analysis. | Sr. Director, Ultragenyx Pharmaceuticals Inc. |
Francesca Domenech (Wuttke) | 2002 | Laurence, Jaffrey | Inhibition of SDF1 - Mediated Megakaryocyte Migration by HIV gp120: A New Mechanism for HIV - Associated Thrombocytopenia. | Founder and Principal, Asten BioPharma Advisors, LLC, New York, NY |